170 related articles for article (PubMed ID: 6449321)
1. Amniotic fluid secretor typing: validation for use in prenatal prediction of myotonic dystrophy.
Teichler-Zallen D; Doherty RA
Clin Genet; 1980 Oct; 18(4):257-67. PubMed ID: 6449321
[TBL] [Abstract][Full Text] [Related]
2. The secretor status of the foetus.
Gibson SL; Ferguson-Smith MA
Clin Genet; 1980 Aug; 18(2):97-102. PubMed ID: 6449320
[TBL] [Abstract][Full Text] [Related]
3. The secretor locus as a marker for prenatal prediction of myotonic dystrophy (DM).
Greiner J; Spengler DH; Krüger J; Tariverdian G
Hum Genet; 1988 Apr; 78(4):330-2. PubMed ID: 3162894
[TBL] [Abstract][Full Text] [Related]
4. Letter: Prenatal prediction of myotonic dystrophy.
Insley J; Bird GW; Harper PS; Pearce GW
Lancet; 1976 Apr; 1(7963):806. PubMed ID: 56616
[No Abstract] [Full Text] [Related]
5. Prenatal prediction in myotonic dystrophy: guidelines for genetic counseling.
Schrott HG; Karp L; Omenn GS
Clin Genet; 1973; 4(1):38-45. PubMed ID: 4570861
[No Abstract] [Full Text] [Related]
6. Myotonic dystrophy: opportunities for prenatal prediction.
Schrott HG; Omenn GS
Neurology; 1975 Aug; 25(8):789-91. PubMed ID: 1171415
[TBL] [Abstract][Full Text] [Related]
7. An analysis procedure illustrated on a triple linkage of use for prenatal diagnosis of myotonic dystrophy.
Renwick JH; Bolling DR
J Med Genet; 1971 Dec; 8(4):399-406. PubMed ID: 5149522
[No Abstract] [Full Text] [Related]
8. Feasibility of predicting the outcome of fetal infection with cytomegalovirus at the time of prenatal diagnosis.
Leruez-Ville M; Stirnemann J; Sellier Y; Guilleminot T; Dejean A; Magny JF; Couderc S; Jacquemard F; Ville Y
Am J Obstet Gynecol; 2016 Sep; 215(3):342.e1-9. PubMed ID: 27063062
[TBL] [Abstract][Full Text] [Related]
9. Genetic linkage confirmed between the locus for myotonic dystrophy and the ABH-secretion and Lutheran blood group loci.
Harper PS; Rivas ML; Bias WB; Hutchinson JR; Dyken PR; McKusick VA
Am J Hum Genet; 1972 May; 24(3):310-6. PubMed ID: 5063795
[No Abstract] [Full Text] [Related]
10. Tissue typing amniotic fluid cells: potential use for detection of contaminating maternal cells.
Niazi M; Coleman DV; Mowbray JF; Blunt S
J Med Genet; 1979 Feb; 16(1):21-3. PubMed ID: 469881
[TBL] [Abstract][Full Text] [Related]
11. [Blood group antigens and ABH secretor status in dystrophia myotonica (Curschmann-Steinert)].
Mielke U; Gramer L; Schimrigk K
Klin Padiatr; 1986; 198(4):312-5. PubMed ID: 3762003
[TBL] [Abstract][Full Text] [Related]
12. [Karyotype analysis of amniotic fluid cells and comparison of chromosomal abnormality rate during second trimester].
Zhang YP; Wu JP; Li XT; Lei CX; Xu JZ; Yin M
Zhonghua Fu Chan Ke Za Zhi; 2011 Sep; 46(9):644-8. PubMed ID: 22176986
[TBL] [Abstract][Full Text] [Related]
13. Second-trimester echogenic bowel and intraamniotic bleeding: association between fetal bowel echogenicity and amniotic fluid spectrophotometry at 410 nm.
Sepulveda W; Reid R; Nicolaidis P; Prendiville O; Chapman RS; Fisk NM
Am J Obstet Gynecol; 1996 Mar; 174(3):839-42. PubMed ID: 8633653
[TBL] [Abstract][Full Text] [Related]
14. Second-trimester amniotic fluid corticotropin-releasing hormone and urocortin in relation to maternal stress and fetal growth in human pregnancy.
La Marca-Ghaemmaghami P; Dainese SM; Stalla G; Haller M; Zimmermann R; Ehlert U
Stress; 2017 May; 20(3):231-240. PubMed ID: 28347187
[TBL] [Abstract][Full Text] [Related]
15. Prenatal diagnosis of Duchenne muscular dystrophy: failure of amniotic fluid and maternal serum N tau-methylhistidine analyses to detect affected fetuses.
Wassner SJ; Li JB; Ladda RL; Lorenz RP; Emery AE
Am J Obstet Gynecol; 1982 May; 143(2):216-9. PubMed ID: 7081334
[TBL] [Abstract][Full Text] [Related]
16. Prenatal diagnosis of congenital myotonic dystrophy and counseling of the pregnant mother: case report and literature review.
Geifman-Holtzman O; Fay K
Am J Med Genet; 1998 Jul; 78(3):250-3. PubMed ID: 9677060
[TBL] [Abstract][Full Text] [Related]
17. ABH secretor status of the fetus: a genetic marker identifiable by amniocentesis.
Harper P; Bias WB; Hutchinson JR; McKusick VA
J Med Genet; 1971 Dec; 8(4):438-40. PubMed ID: 5149527
[No Abstract] [Full Text] [Related]
18. [The distinction of elevated alpha-fetoprotein levels in amniotic fluids for antenatal diagnosis of genetic defects].
Hemke G; Weise W; Düker D
Z Geburtshilfe Perinatol; 1982; 186(3):133-5. PubMed ID: 6181623
[TBL] [Abstract][Full Text] [Related]
19. Significance of opaque discolored amniotic fluid at second-trimester amniocentesis.
Hess LW; Anderson RL; Golbus MS
Obstet Gynecol; 1986 Jan; 67(1):44-6. PubMed ID: 3940336
[TBL] [Abstract][Full Text] [Related]
20. Factor IX and prothrombin in amniotic fluid and fetal plasma: constraints on prenatal diagnosis of hemophilia B and evidence of proteolysis.
Thompson AR
Blood; 1984 Oct; 64(4):867-74. PubMed ID: 6478059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
